Neuroscience
Our Neuroscience research & development team remains committed to advancing our understanding of these disorders and developing breakthrough treatments and solutions for people living with neuropsychiatric, neurodegenerative, and neurological autoantibody-driven diseases.
Despite significant advancements in understanding and treating nervous system disorders, unmet need persists for patients. That’s why, we’ll never stop pushing the boundaries of what is possible.
Despite significant advancements in understanding and treating nervous system disorders, unmet need persists for patients. That’s why, we’ll never stop pushing the boundaries of what is possible.
For nearly seven decades, we have pioneered innovative medicines that have significantly advanced treatment for nervous system disorders.
Focus areas
Latest news
Related stories
Our robust pipeline spans multiple focus areas with a number of programs in development, as well as select novel therapy programs recently approved, or with potential filings in the United States/European Union.
We are committed to partnering with those whose innovative thinking will bring new and creative solutions to the field of medicine.
Find our meeting news, abstracts, and more information about our progress and commitment to developing innovative medicines focused on neurodegenerative disorders